BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6107241)

  • 1. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Somatostatin-like immunoreactivity in chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Dey R; Unger RH
    Horm Metab Res; 1980 Dec; 12(12):656-60. PubMed ID: 6110628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.
    Schusdziarra V; Harris V; Arimura A; Unger RH
    Endocrinology; 1979 Jun; 104(6):1705-8. PubMed ID: 446390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of somatostatin-like immunoreactivity from the lower gut.
    Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.
    Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH
    Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.
    Conlon JM; Srikant CB; Ipp E; Schusdziarra V; Vale W; Unger RH
    J Clin Invest; 1978 Dec; 62(6):1187-93. PubMed ID: 748373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the hormonal status of somatostatin in man.
    Zyznar ES; Pietri AO; Harris V; Unger RH
    Diabetes; 1981 Oct; 30(10):883-6. PubMed ID: 6115787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Pfeiffer EF; Unger RH
    Regul Pept; 1980 Oct; 1(2):89-96. PubMed ID: 6114514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Regul Pept; 1981 Feb; 1(5):353-63. PubMed ID: 7255767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V; Harris V; Unger R
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.